What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
Yasushi Saito spends much of his time researching Internal medicine, Endocrinology, Cell biology, Molecular biology and Immunology.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Eicosapentaenoic acid and Diabetes mellitus.
Yasushi Saito interconnects Platelet-derived growth factor and Growth factor in the investigation of issues within Endocrinology.
His Cell biology research integrates issues from Receptor, Biochemistry, LDL receptor and Vascular smooth muscle.
His work is dedicated to discovering how Molecular biology, IL-2 receptor are connected with Major histocompatibility complex, Homeostasis, Interleukin 21 and T-cell receptor and other disciplines.
His Cholesterol research is multidisciplinary, relying on both Hydroxymethylglutaryl-CoA reductase and Hyperlipidemia.
His most cited work include:
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis (1827 citations)
- A new method for large scale isolation of kidney glomeruli from mice. (429 citations)
- Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice (358 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Endocrinology, Cholesterol, Biochemistry and Cell biology.
Yasushi Saito combines subjects such as Diabetes mellitus and Cardiology with his study of Internal medicine.
His work in Very low-density lipoprotein, Metabolism, Lipid metabolism, Lipoprotein lipase and Insulin is related to Endocrinology.
His specific area of interest is Cholesterol, where Yasushi Saito studies High-density lipoprotein.
Yasushi Saito is interested in Enzyme, which is a field of Biochemistry.
His work deals with themes such as Vascular smooth muscle, Smooth muscle, Growth factor and Cell growth, which intersect with Cell biology.
He most often published in these fields:
- Internal medicine (56.06%)
- Endocrinology (43.52%)
- Cholesterol (13.80%)
What were the highlights of his more recent work (between 2006-2021)?
- Internal medicine (56.06%)
- Endocrinology (43.52%)
- Cardiology (6.62%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Endocrinology, Cardiology, Coronary artery disease and Diabetes mellitus.
His research is interdisciplinary, bridging the disciplines of Eicosapentaenoic acid and Internal medicine.
As part of his studies on Endocrinology, Yasushi Saito often connects relevant subjects like HMG-CoA reductase.
His work investigates the relationship between Cardiology and topics such as Probucol that intersect with problems in Familial hypercholesterolemia.
In his work, Statin, Sudden cardiac death and Clinical endpoint is strongly intertwined with Myocardial infarction, which is a subfield of Coronary artery disease.
His Diabetes mellitus research is multidisciplinary, incorporating perspectives in Relative risk and Risk factor.
Between 2006 and 2021, his most popular works were:
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis (1827 citations)
- IL-23 and Th17 Cells Enhance Th2-Cell–mediated Eosinophilic Airway Inflammation in Mice (338 citations)
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS) (275 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
Yasushi Saito mostly deals with Internal medicine, Endocrinology, Eicosapentaenoic acid, Coronary artery disease and Cardiology.
His Internal medicine course of study focuses on Diabetes mellitus and Risk factor.
His biological study spans a wide range of topics, including Gastroenterology and Cohort study.
Yasushi Saito has researched Eicosapentaenoic acid in several fields, including Randomized controlled trial, Surgery, Docosahexaenoic acid, Arachidonic acid and Thromboxane A2.
His study in the fields of Myocardial infarction under the domain of Cardiology overlaps with other disciplines such as In patient.
His research in Myocardial infarction intersects with topics in Statin and Sudden cardiac death.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
